These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9103917)

  • 21. Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants.
    Hulse GK; Arnold-Reed DE; O'Neil G; Chan CT; Hansson R; O'Neil P
    Addict Biol; 2004 Mar; 9(1):59-65. PubMed ID: 15203440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naltrexone and problems in pain management.
    Vickers AP; Jolly A
    BMJ; 2006 Jan; 332(7534):132-3. PubMed ID: 16424470
    [No Abstract]   [Full Text] [Related]  

  • 23. Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.
    Hulse GK; Arnold-Reed DE; O'Neil G; Chan CT; Hansson RC
    Addict Biol; 2004 Mar; 9(1):67-72. PubMed ID: 15203441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance.
    Arnold-Reed DE; O'Neil P; Holman CD; Bulsara MK; Rodiguez C; Gawthorne G; Tait RJ; Hulse GK
    Am J Drug Alcohol Abuse; 2007; 33(5):655-64. PubMed ID: 17891658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is sustained release natrexone an option for heroin-dependent pregnant women?
    Waal H
    Addiction; 2013 Feb; 108(2):252-3. PubMed ID: 23331879
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacotherapy of addictions.
    Kreek MJ; LaForge KS; Butelman E
    Nat Rev Drug Discov; 2002 Sep; 1(9):710-26. PubMed ID: 12209151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapeutic environments for substance use disorders.
    Gardner TJ; Kosten TR
    Am J Drug Alcohol Abuse; 2007; 33(5):627-9. PubMed ID: 17891655
    [No Abstract]   [Full Text] [Related]  

  • 28. Heroin addiction and naltrexone.
    Byrne A
    Aust Fam Physician; 1998 May; 27(5):344. PubMed ID: 9612997
    [No Abstract]   [Full Text] [Related]  

  • 29. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of drugs in the management of drug dependence.
    Eddy NB
    J Tenn Med Assoc; 1967 Mar; 60(3):269-73. PubMed ID: 6042204
    [No Abstract]   [Full Text] [Related]  

  • 31. Narcotic analgesics and antagonists.
    Lewis JW; Bentley KW; Cowan A
    Annu Rev Pharmacol; 1971; 11():241-70. PubMed ID: 4948499
    [No Abstract]   [Full Text] [Related]  

  • 32. What is the issue?: pseudoaddiction or undertreatment of pain.
    Kowal N
    Nurs Econ; 1999; 17(6):348-9. PubMed ID: 10711190
    [No Abstract]   [Full Text] [Related]  

  • 33. Persistent analgesia in former opiate addicts is resistant to blockade of endogenous opioids.
    Liebmann PM; Lehofer M; Moser M; Hoehn-Saric R; Legl T; Pernhaupt G; Schauenstein K
    Biol Psychiatry; 1997 Nov; 42(10):962-4. PubMed ID: 9359985
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-acting injectable naltrexone for the treatment of alcohol dependence.
    Mannelli P; Peindl K; Masand PS; Patkar AA
    Expert Rev Neurother; 2007 Oct; 7(10):1265-77. PubMed ID: 17939765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naltrexone (vivitrol)--a once-monthly injection for alcoholism.
    Med Lett Drugs Ther; 2006 Jul; 48(1240):63-4. PubMed ID: 16874283
    [No Abstract]   [Full Text] [Related]  

  • 36. A patient-supported clinical trial.
    O'Brien C
    Ann Neurol; 2010 Aug; 68(2):124-5. PubMed ID: 20623586
    [No Abstract]   [Full Text] [Related]  

  • 37. Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone.
    Dean RL; Todtenkopf MS; Deaver DR; Arastu MF; Dong N; Reitano K; O'Driscoll K; Kriksciukaite K; Gastfriend DR
    Pharmacol Biochem Behav; 2008 Jun; 89(4):515-22. PubMed ID: 18342360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naltrexone implant and blood naltrexone levels over pregnancy.
    Hulse GK; Arnold-Reed DE; O'Neil G; Hansson RC
    Aust N Z J Obstet Gynaecol; 2003 Oct; 43(5):386-8. PubMed ID: 14717319
    [No Abstract]   [Full Text] [Related]  

  • 39. Isobolographic analysis of multimodal analgesia in an animal model of visceral acute pain.
    Miranda HF; Prieto JC; Puig MM; Pinardi G
    Pharmacol Biochem Behav; 2008 Feb; 88(4):481-6. PubMed ID: 18023854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unplanned admissions to two Sydney public hospitals after naltrexone implants.
    Brewer CL
    Med J Aust; 2008 Oct; 189(8):470; author reply 470-1. PubMed ID: 19024886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.